Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease

This publication has 59 references indexed in Scilit:

• Dual blockade of the rennin–angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis
  Clinical and Experimental Nephrology, 2008
• Prevalence of Chronic Kidney Disease in the United States
  JAMA, 2007
• Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysis
  Diabetic Medicine, 2007
• Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
  Circulation, 2006
• Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms
  Kidney International, 2006
• Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in Hypertension
  Hypertension, 2005
• Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease
  Journal of Human Hypertension, 2003
• Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors
  Journal of the Renin-Angiotensin-Aldosterone System, 2000
• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  The Lancet, 1999
• Effect of Calcium Channel or β-Blockade on the Progression of Diabetic Nephropathy in African Americans
  Hypertension, 1997